Researchers: Bellinda Benhamú, Mar Martín-Fontecha, Henar Vázquez-Villa, María L López-Rodríguez, Silvia Ortega-Gutiérrez
Aging is considered the main risk factor for many chronic diseases that frequently appear at advanced ages. However, the inevitability of this process is being questioned by recent research that suggests that senescent cells have specific features that differentiate them from younger cells and that removal of these cells ameliorates senescent phenotype and associated diseases. This opens the door to the design of tailored therapeutic interventions aimed at reducing and delaying the impact of senescence in life, that is, extending healthspan and treating aging as another chronic disease. Although these ideas are still far from reaching the bedside, it is conceivable that they will revolutionize the way we understand aging in the next decades. In this review, we analyze the main and well-validated cellular pathways and targets related to senescence as well as their implication in aging-associated diseases. In addition, the most relevant small molecules with senotherapeutic potential, with a special emphasis on their mechanism of action, ongoing clinical trials, and potential limitations, are discussed. Finally, a brief overview of alternative strategies that go beyond the small molecule field, together with our perspectives for the future of the field, is provided.
References
- The hallmarks of aging.
- Treating Senescence like Cancer: Novel Perspectives in Senotherapy of Chronic Diseases.
- Senolytic drugs: from discovery to translation.
- A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials.
- Small molecule SIRT1 activators for the treatment of aging and age-related diseases.
- The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation.
- Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment.
- Old blood from heterochronic parabionts accelerates vascular aging in young mice: transcriptomic signature of pathologic smooth muscle remodeling.
- Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain.
Topic: healthspan (Graph Available)